Western Blot showing specific immunolabeling of Ly-6K in KK47 human bladder carcinoma cells, LY-6K siRNA, but not scrambled siRNA knocked down Ly-6K expression. A GAPDH antibody was used as a protein loading control. Data courtesy of Masuda et al.
Bulk Order Anti-Ly-6k Antibody
To identify novel human head-and-neck squamous cell carcinoma (HNSCC)-associated Ly-6 members with squamous cell-associated expression patterns, a comprehensive gene-screening was performed, followed by expression analysis. Using this approach, the Ly-6K gene was identified as a novel member of the human Ly-6 family. Results show that Ly-6K is a potential target antigen for the diagnosis and therapy of HNSCC.
Antigen Affinity Purified
Synthetic peptide corresponding to amino acids from an internal sequence of the human Ly-6k protein
Recommended that the undiluted antibody be aliquoted into smaller working volumes (10-30 uL/vial depending on usage) upon arrival and stored long term at -20° C or -80° C, while keeping a working aliquot stored at 4° C for short term. Avoid freeze/thaw cycles. Stable for at least 1 year.
PBS + 0.02% NaN3
WB Brain: 1:500-1:1000
Reacts with the 14 kDa human Ly-6K protein
Western blots performed on each lot.
For research use only. Not intended for therapeutic or diagnostic use. Use of all products is subject to our terms and conditions, which can be viewed on our website.
After date of receipt, stable for at least 1 year at -20°C.